Saturday December 16th 2017

Fingolimod Efficacy and Safety in an African-American Patient Subgroup from FREEDOMS II (P3.156)

CONCLUSIONS:Relapse rates and focal MRI activity were lower in AAs treated with fingolimod than with placebo; statistically significant differences were not expected owing to the small patient numbers. Fingolimod safety was consistent with the overall FREEDOMS II population.Study Supported by:Novartis Pharmaceuticals Corporation.Disclosure: Dr. Coyle has received personal compensation for activities with Acorda, Accordant, Bayer, Biogen Idec, Merck Serono/Pfizer, Genzyme/Sanofi Aventis, Mylan, Novartis, Genentech/Roche, and Teva Neuroscience. Dr. Coyle has received research support from Actelion, Novartis, and Opexa. Dr. Cree has received personal compensation for activities with Abbvie, Biogen Idec, EMD Serono, Genzyme Corporation, Novartis, Sanofi-Aventis Pharmaceuticals, Inc., and Teva …

Continue reading: 

Fingolimod Efficacy and Safety in an African-American Patient Subgroup from FREEDOMS II (P3.156)

Leave a Comment

More from category

MS Activists Celebrate 2017 State Policy Impact
MS Activists Celebrate 2017 State Policy Impact

/About-the-Society/News/MS-Activists-Celebrate-2017-State-Policy-Impact [Read More]

MS Research Program Funding Authorized by President Trump
MS Research Program Funding Authorized by President Trump

/About-the-Society/News/MS-Research-Program-Funding-Authorized-by-Presiden [Read More]

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]